Diabetes and mental illness: Factors to keep in mind

Consultant

Volumn 43, Issue 3, 2003, Pages 337-344

  Dixon, Lisa B ^a,b   Wohlheiter, Karen ^a,b  

^a UNIVERSITY OF MARYLAND   (United States)

^b UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMMUNICATION DISORDER; COMORBIDITY; DIABETES MELLITUS; DISEASE PREDISPOSITION; GLUCOSE INTOLERANCE; HUMAN; ILLNESS BEHAVIOR; IMPAIRED GLUCOSE TOLERANCE; INSULIN RESISTANCE; MENTAL DISEASE; NUTRITIONAL DEFICIENCY; OBESITY; PATIENT CARE; PRIORITY JOURNAL; PSYCHOSOCIAL WITHDRAWAL; REVIEW; SCHIZOPHRENIA; TREATMENT PLANNING;

EID: 0037348854     PISSN: 00107069     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (30)

1. Jeste DV, Gladsjo JA, Lindamer LA, Lacro JP. Medical comorbidity in schizophrenia. Schizophr Bull. 1996;22:413-430.
2. Felker B, Yazel JJ, Short D. Mortality and medical comorbidity among psychiatric patients: a review. Psychiatr Serv. 1996;47:1356-1363.
3. Mukherjee S, Decina P, Bocola V, et al. Diabetes mellitus in schizophrenic patients. Compr Psychiatry 1996;37:68-73.
4. McKee HA, D'Arcy PF, Wilson PJ. Diabetes and schizophrenia - a preliminary study. J Clin Hosp Pharm. 1986;11:297-299.
5. Dynes JB. Diabetes in schizophrenia and diabetes in nonpsychotic medical patients. Dis Nerv Syst. 1969;30:341-344.
6. Richter D. Biochemical aspects of schizophrenia. In: Richter D, ed. Schizophrenia: Somatic Aspects. London: Pergamon Press; 1957.
7. Dixon L, Weiden PJ, Delahanty J, et al. Prevalence and correlates of diabetes in national schizophrenia samples. Schizophr Bull. 2000;26:903-912.
8. Adams PF, Marano MA. Current estimates from the National Health Interview Survey, 1994. National Center for Health Statistics. Vital Health Stat 10. 1995;10:193.
9. Cantor AB, Krischer JP, Cuthbertson DD, et al. Age and family relationship accentuate the risk of insulin-dependent diabetes mellitus (IDDM) in relatives of patients with IDDM. J Clin Endocrinol Metab. 1995;80:3739-3743.
10. Casparie A. Epidemiology of type II diabetes mellitus and ageing of the population: health policy implications and recommendations for epidemiological research. Int J Epidemiol. 1991;20(suppl 1): S25-S29.
11. Self-reported prevalence of diabetes among Hispanics - United States, 1994-1997. MMWR. 1999;48:8-12.
12. Harris MI. Diabetes in America: epidemiology and scope of the problem. Diabetes Care. 1998;21 (suppl 3):C11-C14.
13. Ryan MC, Thakore JH. Physical consequences of schizophrenia and its treatment: the metabolic syndrome. Life Sci. 2002;71:239-257.
14. Finney GO. Juvenile onset diabetes and schizophrenia. Lancet. 1989;18:1214-1215.
15. Brambilla F, Guastalla A, Guerrini A, et al. Glucose-insulin metabolism in chronic schizophrenia. Dis Nerv Syst. 1976;37:98-103.
16. Holden RJ. The estrogen connection: the etiological relationship between diabetes, cancer, rheumatoid arthritis and psychiatric disorders. Med Hypotheses. 1995;45:169-189.
17. Holden RJ. Schizophrenia, suicide and the serotonin story. Med Hypotheses. 1995;44:379-391.
18. Holden RJ, Mooney PA. Schizophrenia is a diabetic brain state: an elucidation of impaired neurometabolism. Med Hypotheses. 1994;43:420-435.
19. Ryan MC, Collins P, Thakore JH. Impaired fasting glucose tolerance in first-episode, drug-naive patients with schizophrenia. Am J Psychiatry. 2003; 160:284-289.
20. de Boer C, Gaete HP. Neuroleptic malignant syndrome and diabetic keto-acidosis. Br J Psychiatry 1992;161:856-858.
21. Kamran A, Doraiswamy PM, Jane JL, et al. Severe hyperglycemia associated with high doses of clozapine. Am J Psychiatry. 1994;151:1395.
22. Allison DB, Fontaine KR, Heo M, et al. The distribution of body mass index among individuals with and without schizophrenia. J Clin Psychiatry 1999; 60:215-220.
23. Masand P, ed. Weight gain and antipsychotic medications. Journal of Clinical Psychiatry Visuals. Memphis: Physicians Postgraduate Press; 1999. Theme issue.
24. Layman E. Psychological effect of physical activity. In: Exercise and Sport Sciences Reviews. American College of Sports Medicine Series. New York: Academic Press; 1974:33-70.
25. Pelham TW, Campagna PD. Benefits of exercise in psychiatric rehabilitation of persons with schizophrenia. Can J Rehab. 1991;4:159-168.
26. Pelham TW, Campagna PD, Ritvo PG, et al. The effects of exercise therapy on clients in a psychiatric rehabilitation program. Psychosocial Rehab J. 1993; 16:75-84.
27. Cradock-O'Leary J, Young AS, Yano EM, et al. Use of general medical services by VA patients with psychiatric disorders. Psychiatr Serv. 2002;53:874-878.
28. Folsom DP, McCahill M, Bartels SJ, et al. Medical comorbidity and receipt of medical care by older homeless people with schizophrenia or depression. Psychiatr Serv. 2002;53:1456-1460.
29. Dickerson F, McNary S, Brown C, et al. Somatic healthcare utilization among adults with serious mental illness who are receiving community psychiatric services. Med Care. In press.
30. Redelmeier DA, Tan SH, Booth GL. The treatment of unrelated disorders in patients with chronic medical diseases. N Engl J Med. 1998;338:1516-1520.